Skip to main content

Table 2 Frequency of nonadherence types per interval and cumulative probability of adherence to ART among a cohort of mothers (N = 1572) and NVP among a cohort of infants (N = 2370) from 6 weeks to 18 months postpartum in South Africa followed in 2012–2014 (unweighted)

From: Longitudinal adherence to maternal antiretroviral therapy and infant Nevirapine prophylaxis from 6 weeks to 18 months postpartum amongst a cohort of mothers and infants in South Africa

 

Follow-up intervals from 6 weeks to 18 months postpartum

6 weeks - 14 weeks

14 weeks - 6 months

6 months - 9 months

9 months - 12 months

12 months - 15 months

15 months - 18 months

Adherence to ART among mothers reported on ART

 Total number of mothers entering interval

n = 1026

n = 902

n = 866

n = 833

n = 800

n = 832

  Cumulative probability of adherencea

85.0 (82.8–87.0)

79.1 (76.6–81.4)

74.2 (71.6–76.6)

71.1 (67.0–72.2)

67.3 (64.6–69.9)

63.4 (60.7–66.0)

  Total adherence events during interval

861

820

801

777

749

763

  Total nonadherence events during interval

165

82

65

56

51

69

   Taking ART but missed > 5% doses

25 (15.2)

17 (20.7)

17 (26.2)

9 (16.1)

8 (15.7)

8 (11.6)

   Stopped taking ART during interval (not according to care)

140 (84.8)

65 (79.3)

48 (73.8)

47 (83.9)

43 (84.3)

61 (88.4)

Mothers not included in the analysis at each stage and reason for exclusion

 Total number of mothers not reporting on ART at interval

n = 546

n = 670

n = 706

n = 739

n = 772

n = 740

  Missed interview

462 (84.6)

508 (75.8)

528 (74.8)

544 (73.6)

542 (70.2)

473 (63.9)

  Non-mother caregiver gave interview

84 (15.4)

92 (13.7)

94 (13.3)

111 (15.0)

150 (19.4)

185 (25.0)

  No longer on ART

0 (0.00)

70 (10.5)

84 (11.9)

84 (11.4)

80 (10.4)

82 (11.1)

Adherence to NVP among infants reported on NVP

 Total number of infants assessed for adherence in interval

n = 1145

n = 702

n = 426

n = 248

n = 125

n = 52

  Cumulative probability of adherencea

96.4 (94.3–97.8)

92.3 (89.8–94.2)

88.8 (85.9–91.2)

86.9 (83.6–89.6)

81.6 (76.9–85.5)

74.5 (70.2–81.9)

  Total adherence events during interval

1102

670

403

236

113

49

  Total nonadherence events during interval

43

32

23

12

12

3

   Taking ART but missed > 5% doses

8 (18.6)

12 (37.5)

5 (21.7)

3 (25.0)

5 (41.7)

0 (0.0)

   Stopped taking NVP during interval (not according to care)

35 (81.4)

20 (62.5)

18 (78.3)

9 (75.0)

7 (58.3)

3 (100.0)

Infants not included in the analysis during each interval and reason for exclusion

 Total number of infants not reporting on NVP at interval

n = 1225

n = 1668

n = 1944

n = 2122

n = 2245

n = 2318

  Missed interview

338 (27.6)

405 (24.3)

437 (22.5)

448 (21.1)

425 (18.9)

389 (16.8)

  Appropriately stopped NVP

887 (72.4)

1263 (75.7)

1507 (77.5)

1674 (78.9)

1821 (81.1)

1929 (83.2)

   Never breastfed during interval

850 (95.8)

1183 (93.7)

1404 (93.2)

1542 (92.1)

1678 (92.2)

1784 (92.5)

   Clinician said to stop NVP

37 (4.2)

80 (6.3)

103 (6.8)

132 (7.9)

143 (7.8)

145 (7.5)

  1. aSurvivor function (probability of adherence) is calculated over full data and evaluated at indicated times; it is not calculated from aggregates shown in this table